PROS1 and COVID-19: In our case, we further simplified the original method by obviating the second confirmatory ELISA that uses the recombinant stabilized S protein, which represented a reduction in cost and time.With these changes, a validation study was performed for both tests to evaluate their diagnostic performance and to assess it in the specific context of Mexico, prior the introduction of COVID-19 vaccination.